• | statements about the Company’s future performance; |
• | projections of the Company’s results of operations or financial condition; |
• | statements regarding the Company’s plans, objectives or goals, including those relating to strategies, initiatives, competition, acquisitions, dispositions and/or its products; |
• | expectations concerning the costs associated with the suspension or closure of operations at any of the Company’s plants and future plans with respect to any such plants; |
• | expectations concerning the costs associated with the significant capital expenditure projects at any of the Company’s plants and future plans with respect to any such projects; |
• | expectations regarding the extension or renewal of the Company’s credit facilities including changes to terms, covenants or ratios; |
• | expectations concerning dividend payments and share buy-backs; |
• | statements concerning the Company’s corporate and tax domiciles and structures and potential changes to them, including potential tax charges; |
• | uncertainty from the expected discontinuance of LIBOR and transition to any other interest rate benchmark; |
• | statements regarding tax liabilities and related audits, reviews and proceedings; |
• | statements regarding the possible consequences and/or potential outcome of legal proceedings brought against us and the potential liabilities, if any, associated with such proceedings; |
• | expectations about the timing and amount of contributions to Asbestos Injuries Compensation Fund (AICF), a special purpose fund for the compensation of proven Australian asbestos-related personal injury and death claims; |
• | expectations concerning the adequacy of the Company’s warranty provisions and estimates for future warranty-related costs; |
• | statements regarding the Company’s ability to manage legal and regulatory matters (including but not limited to product liability, environmental, intellectual property and competition law matters) and to resolve any such pending legal and regulatory matters within current estimates and in anticipation of certain third-party recoveries; and |
• | statements about economic conditions, such as changes in the US economic or housing recovery or changes in the market conditions in the Asia Pacific region, the levels of new home construction and home renovations, unemployment levels, changes in consumer income, changes or stability in housing values, the availability of mortgages and other financing, mortgage and other interest rates, housing affordability and supply, the levels of foreclosures and home resales, currency exchange rates, and builder and consumer confidence. |
James Hardie Industries plc | |||
Date: | 2 October 2019 | By: | /s/ Natasha Mercer |
Natasha Mercer | |||
Company Secretary | |||
Name of entity |
James Hardie Industries plc |
ABN |
097 829 895 Incorporated in Ireland. The liability of members is limited. |
1 | +Class of +securities issued or to be issued | Ordinary shares/CDIs issued on vesting of Restricted Stock Units (RSUs). | ||
2 | Number of +securities issued or to be issued (if known) or maximum number which may be issued | RSUs vesting: 210,003 ordinary shares/CDIs. | ||
3 | Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) | RSUs vesting: 210,003 ordinary shares/CDIs issued on vesting of RSUs. | ||
4 | Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | Yes, ordinary shares/CDIs issued on vesting of RSUs rank equally with issued ordinary shares/CDIs. | ||
5 | Issue price or consideration | Vesting of RSUs: 210,003. No amount payable. | ||
6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) | Vesting of RSUs: (1) 207,271 RSUs vesting pursuant to the James Hardie Industries Long Term Incentive Plan 2006 (2006 Plan). (2) 2,732 RSUs vesting pursuant to the James Hardie Industries Long Term Incentive Plan 2001 (2001 Plan) | ||
6a | Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i | No. Equity securities issued under the 2001 Plan are no longer the subject of security holder approval. | ||
6b | The date the security holder resolution under rule 7.1A was passed | Not applicable | ||
6c | Number of +securities issued without security holder approval under rule 7.1 | 0 | ||
6d | Number of +securities issued with security holder approval under rule 7.1A | Not applicable | ||
6e | Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) | Not applicable | ||
6f | Number of +securities issued under an exception in rule 7.2 | 210,003 | ||
6g | If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. | Not applicable | ||
6h | If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements | Not applicable | ||
6i | Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements | 65,730,771 (Annexure 1 attached) | ||
7 | +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. | 16 September 2019 | ||
Number | +Class | |||
8 | Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable) | 442,480,337 | Ordinary shares/CDIs | |
Number | +Class | ||
9 | Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable) | 853,457 (equivalent to 853,457 CDIs) 3,610,102 (equivalent to 3,610,102 CDIs) 138,189 2006 Plan RSUs have been cancelled. 9,976 2001 Plan RSUs have been cancelled. | 2001 Plan RSUs 2006 Plan RSUs |
Number | +Class | ||
10 | Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests) | Ordinary shares/CDIs issued on vesting of RSUs rank for dividends equally with issued ordinary shares/CDIs. | |
11 | Is security holder approval required? | Not applicable |
12 | Is the issue renounceable or non-renounceable? | Not applicable |
13 | Ratio in which the +securities will be offered | Not applicable |
14 | +Class of +securities to which the offer relates | Not applicable |
15 | +Record date to determine entitlements | Not applicable |
16 | Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? | Not applicable |
17 | Policy for deciding entitlements in relation to fractions | Not applicable |
18 | Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. | Not applicable |
19 | Closing date for receipt of acceptances or renunciations | Not applicable |
20 | Names of any underwriters | Not applicable |
21 | Amount of any underwriting fee or commission | Not applicable |
22 | Names of any brokers to the issue | Not applicable |
23 | Fee or commission payable to the broker to the issue | Not applicable |
24 | Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders | Not applicable |
25 | If the issue is contingent on security holders’ approval, the date of the meeting | Not applicable |
26 | Date entitlement and acceptance form and offer documents will be sent to persons entitled | Not applicable |
27 | If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders | Not applicable |
28 | Date rights trading will begin (if applicable) | Not applicable |
29 | Date rights trading will end (if applicable) | Not applicable |
30 | How do security holders sell their entitlements in full through a broker? | Not applicable |
31 | How do security holders sell part of their entitlements through a broker and accept for the balance? | Not applicable |
32 | How do security holders dispose of their entitlements (except by sale through a broker)? | Not applicable |
33 | +Issue date | Not applicable |
34 | Type of +securities (tick one) | |
(a) | +Securities described in Part 1 | |
(b) | All other +securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities | |
Tick to indicate you are providing the information or documents | ||
35 | If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders | |
36 | If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over | |
37 | A copy of any trust deed for the additional +securities | |
38 | Number of +securities for which +quotation is sought | Not applicable | |
39 | +Class of +securities for which quotation is sought | Not applicable | |
40 | Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | Not applicable | |
41 | Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another +security, clearly identify that other +security) | Not applicable | |
Number | +Class | ||
42 | Number and +class of all +securities quoted on ASX (including the +securities in clause 38) | Not applicable | Not applicable |
1 | +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on any conditions it decides. |
2 | We warrant the following to ASX. |
• | The issue of the +securities to be quoted complies with the law and is not for an illegal purpose. |
• | There is no reason why those +securities should not be granted +quotation. |
• | An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act. |
• | Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted. |
• | If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted. |
3 | We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement. |
4 | We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete. |
Print name: | Natasha Mercer..................................... |
Rule 7.1 – Issues exceeding 15% of capital | |
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated | |
Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue | 441,524,118 |
Add the following: • Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2 • Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval • Number of partly paid +ordinary securities that became fully paid in that 12 month period Note: • Include only ordinary securities here – other classes of equity securities cannot be added • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items | 956,219 Not applicable Not applicable |
Subtract the number of fully paid +ordinary securities cancelled during that 12 month period | 0 |
“A” | 442,480,337 |
Step 2: Calculate 15% of “A” | |
“B” | 0.15 [Note: this value cannot be changed] |
Multiply “A” by 0.15 | 66,372,050 |
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used | |
Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items | 641,279 |
“C” | 641,279 |
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1 | |
“A” x 0.15 Note: number must be same as shown in Step 2 | 66,372,050 |
Subtract “C” Note: number must be same as shown in Step 3 | (641,279) |
Total [“A” x 0.15] – “C” | 65,730,771 [Note: this is the remaining placement capacity under rule 7.1] |
Rule 7.1A – Additional placement capacity for eligible entities | |
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated | |
“A” Note: number must be same as shown in Step 1 of Part 1 | Not applicable |
Step 2: Calculate 10% of “A” | |
“D” | 0.10 Note: this value cannot be changed |
Multiply “A” by 0.10 | Not applicable |
“E” | Not applicable |
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used | |
Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items | Not applicable |
“E” | Not applicable |
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A | |
“A” x 0.10 Note: number must be same as shown in Step 2 | Not applicable |
Subtract “E” Note: number must be same as shown in Step 3 | Not applicable |
Total [“A” x 0.10] – “E” | Not applicable Note: this is the remaining placement capacity under rule 7.1A |
Name of entity |
James Hardie Industries plc |
ABN |
097 829 895 Incorporated in Ireland. The liability of members is limited. |
1 | +Class of +securities issued or to be issued | Ordinary shares/CDIs issued on vesting of Restricted Stock Units (RSUs). | ||
2 | Number of +securities issued or to be issued (if known) or maximum number which may be issued | RSUs vesting: 219,390 ordinary shares/CDIs. | ||
3 | Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) | RSUs vesting: 219,390 ordinary shares/CDIs issued on vesting of RSUs. | ||
4 | Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | Yes, ordinary shares/CDIs issued on vesting of RSUs rank equally with issued ordinary shares/CDIs. | ||
5 | Issue price or consideration | Vesting of RSUs: 219,390. No amount payable. | ||
6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) | Vesting of RSUs: 219,390 RSUs vesting pursuant to the James Hardie Industries Long Term Incentive Plan 2006 (2006 Plan). | ||
6a | Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i | No. Equity securities issued under the 2001 Plan are no longer the subject of security holder approval. | ||
6b | The date the security holder resolution under rule 7.1A was passed | Not applicable | ||
6c | Number of +securities issued without security holder approval under rule 7.1 | 0 | ||
6d | Number of +securities issued with security holder approval under rule 7.1A | Not applicable | ||
6e | Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) | Not applicable | ||
6f | Number of +securities issued under an exception in rule 7.2 | 219,390 | ||
6g | If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. | Not applicable | ||
6h | If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements | Not applicable | ||
6i | Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements | 65,763,680 (Annexure 1 attached) | ||
7 | +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. | 17 September 2019 | ||
Number | +Class | |||
8 | Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable) | 442,699,727 | Ordinary shares/CDIs | |
Number | +Class | ||
9 | Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable) | 853,457 (equivalent to 853,457 CDIs) 3,390,712 (equivalent to 3,390,712 CDIs) No 2006 Plan RSUs have been cancelled. No 2001 Plan RSUs have been cancelled. | 2001 Plan RSUs 2006 Plan RSUs |
Number | +Class | ||
10 | Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests) | Ordinary shares/CDIs issued on vesting of RSUs rank for dividends equally with issued ordinary shares/CDIs. | |
11 | Is security holder approval required? | Not applicable |
12 | Is the issue renounceable or non-renounceable? | Not applicable |
13 | Ratio in which the +securities will be offered | Not applicable |
14 | +Class of +securities to which the offer relates | Not applicable |
15 | +Record date to determine entitlements | Not applicable |
16 | Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? | Not applicable |
17 | Policy for deciding entitlements in relation to fractions | Not applicable |
18 | Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. | Not applicable |
19 | Closing date for receipt of acceptances or renunciations | Not applicable |
20 | Names of any underwriters | Not applicable |
21 | Amount of any underwriting fee or commission | Not applicable |
22 | Names of any brokers to the issue | Not applicable |
23 | Fee or commission payable to the broker to the issue | Not applicable |
24 | Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders | Not applicable |
25 | If the issue is contingent on security holders’ approval, the date of the meeting | Not applicable |
26 | Date entitlement and acceptance form and offer documents will be sent to persons entitled | Not applicable |
27 | If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders | Not applicable |
28 | Date rights trading will begin (if applicable) | Not applicable |
29 | Date rights trading will end (if applicable) | Not applicable |
30 | How do security holders sell their entitlements in full through a broker? | Not applicable |
31 | How do security holders sell part of their entitlements through a broker and accept for the balance? | Not applicable |
32 | How do security holders dispose of their entitlements (except by sale through a broker)? | Not applicable |
33 | +Issue date | Not applicable |
34 | Type of +securities (tick one) | |
(a) | +Securities described in Part 1 | |
(b) | All other +securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities | |
Tick to indicate you are providing the information or documents | ||
35 | If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders | |
36 | If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over | |
37 | A copy of any trust deed for the additional +securities | |
38 | Number of +securities for which +quotation is sought | Not applicable | |
39 | +Class of +securities for which quotation is sought | Not applicable | |
40 | Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | Not applicable | |
41 | Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another +security, clearly identify that other +security) | Not applicable | |
Number | +Class | ||
42 | Number and +class of all +securities quoted on ASX (including the +securities in clause 38) | Not applicable | Not applicable |
1 | +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on any conditions it decides. |
2 | We warrant the following to ASX. |
• | The issue of the +securities to be quoted complies with the law and is not for an illegal purpose. |
• | There is no reason why those +securities should not be granted +quotation. |
• | An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act. |
• | Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted. |
• | If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted. |
3 | We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement. |
4 | We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete. |
Print name: | Natasha Mercer..................................... |
Rule 7.1 – Issues exceeding 15% of capital | |
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated | |
Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue | 441,524,118 |
Add the following: • Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2 • Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval • Number of partly paid +ordinary securities that became fully paid in that 12 month period Note: • Include only ordinary securities here – other classes of equity securities cannot be added • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items | 1,175,609 Not applicable Not applicable |
Subtract the number of fully paid +ordinary securities cancelled during that 12 month period | 0 |
“A” | 442,699,727 |
Step 2: Calculate 15% of “A” | |
“B” | 0.15 [Note: this value cannot be changed] |
Multiply “A” by 0.15 | 66,404,959 |
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used | |
Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items | 641,279 |
“C” | 641,279 |
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1 | |
“A” x 0.15 Note: number must be same as shown in Step 2 | 66,404,959 |
Subtract “C” Note: number must be same as shown in Step 3 | (641,279) |
Total [“A” x 0.15] – “C” | 65,763,680 [Note: this is the remaining placement capacity under rule 7.1] |
Rule 7.1A – Additional placement capacity for eligible entities | |
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated | |
“A” Note: number must be same as shown in Step 1 of Part 1 | Not applicable |
Step 2: Calculate 10% of “A” | |
“D” | 0.10 Note: this value cannot be changed |
Multiply “A” by 0.10 | Not applicable |
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used | |
Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items | Not applicable |
“E” | Not applicable |
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A | |
“A” x 0.10 Note: number must be same as shown in Step 2 | Not applicable |
Subtract “E” Note: number must be same as shown in Step 3 | Not applicable |
Total [“A” x 0.10] – “E” | Not applicable Note: this is the remaining placement capacity under rule 7.1A |